Daré Bioscience, Inc

DARE
Real-time BATS EXCHANGE - 01/23 04:38:33 pm
1.38USD
-18.82%
Prev.1.7000
Open1.5000
High1.5500
Low1.3300
Volume3 589 094
Financials
Sales 2019 -
EBIT 2019 -14,3 M
Net income 2019 -14,8 M
Debt 2019 -
Yield 2019 -
P/E ratio 2019 -1,46x
P/E ratio 2020 -1,90x
Capi. / Sales2019 infx
Capi. / Sales2020 43,5x
Capitalization 27,2 M
Company
Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is...
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2020-01-22 Special Situation
Trading Rating :
Investor Rating : -
Latest news
01/15Daré Bioscience Schedules Conference Call for January 22, 2020 to Discuss Ovaprene® Licensing Agreement and General Corporate Update
GL
01/14The first earnings season of 2020 starts
01/14DARE BIOSCIENCE : Bayer and Dare Bioscience enter into exclusive license agreement for U.S. commercial rights to investigational hormone-free, monthly contraceptive Ovaprene
AQ
01/13Dare Bioscience More Than Double After Bayer Licensing Deal
DJ
01/13Dare Biosciences Shares Up 79% on Bayer Licensing Agreement
DJ
01/13DARE BIOSCIENCE, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
01/13DARE BIOSCIENCE :  Bayer and Daré Bioscience Announce Exclusive Licensing Agreement for U.S. Commercial Rights to Ovaprene ®, an Investigational Hormone-Free, Monthly Contraceptive
BU
01/09DARE BIOSCIENCE, INC. : Other Events (form 8-K)
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishNeutral
Resistance1,701,701,68
Spread/Res.-19%-19%-18%
Spread/Supp.28%28%91%
Support1,081,080,72